| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |